David Malcolm Crowe

This inventor holds 8 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Asceneuron Sa, Kalvista Pharmaceuticals Limited. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Malcolm Crowe. Retrieved from https://idiyas.com/inventor/david-malcolm-crowe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 87.5

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 24(Granted Patents)

Company Filing History:

Kalvista Pharmaceuticals Limited

patents

Years Active: 2020-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12398130 - Acid addition salts of piperazine derivatives (2025-08-26),

2. 12195455 - Succinate and fumarate acid addition salts of piperazine derivatives (2025-01-14),

3. 11739068 - Polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide and salts thereof (2023-08-29),

4. 11591327 - Acid addition salts of piperazine derivatives (2023-02-28),

5. 11584735 - Solid forms of a plasma kallikrein inhibitor and salts thereof (2023-02-21),

6. 11230537 - Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl} methyl)pyrazole-4-carboxamide as iallikrein inhibitors (2022-01-25),

7. 10752607 - Polymorphs of N-[(6-cyano-2-fluoro)-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide as kallikrein inhibitors (2020-08-25),

8. 10696668 - Acid addition salts of piperazine derivatives (2020-06-30),

Title: David Malcolm Crowe - Innovative Inventor from Reading, GB

Introduction: David Malcolm Crowe is a renowned inventor hailing from Reading, GB, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: David Malcolm Crowe holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, David Malcolm Crowe has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized the industry.

Collaborations: Throughout his career, David Malcolm Crowe has collaborated with top companies, banks, and patent attorneys to bring his inventions to life, solidifying his reputation as a visionary inventor in the global innovation landscape.

Conclusion: David Malcolm Crowe's passion for innovation and relentless pursuit of excellence have cemented his legacy as a pioneering inventor, inspiring future generations to push the boundaries of what is possible in the world of technology and science.

Profile summary based on public USPTO records.